查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475911

骨髓移植市场：依地区：全球产业分析、规模、占有率、成长、趋势、预测，2024-2031年

Bone Marrow Transplantation Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 190 Pages | 商品交期: 2-5个工作天内

价格
简介目录

该研究报告对全球骨髓移植市场进行了全面分析，深入瞭解了市场趋势、成长动力、课题和新兴机会。这份研究报告对市场进行了深入研究，重点关注揭示 2024 年至 2031 年市场轨蹟的关键统计数据和预测。

重要见解

  • 骨髓移植市场规模（2024年）：111.37亿美元
  • 市场预测（2031年）：143.36亿美元
  • 全球市场成长率（2024-2031年复合年增长率）：3.67%

骨髓移植市场 - 报告范围：

骨髓移植市场包括治疗各种血液疾病、实体肿瘤和自体免疫疾病所必需的程序和技术。这些包括同种异体移植、自体移植、造血干细胞收穫、预处理方案和支持性治疗。该市场为医院、移植中心和专科诊所提供服务，提供先进的移植解决方案，以改善患者的治疗效果和生活品质。

市场成长动力：

全球骨髓移植市场由多种成长因素推动。血液系统恶性肿瘤和自体免疫疾病的盛行率不断增加，加上移植技术和支持治疗的进步，正在推动骨髓移植手术的需求。移植物处理、免疫抑制治疗和移植物抗宿主疾病 (GVHD) 预防方面的创新正在提高移植成功率，并将移植资格扩大到更广泛的患者群体。此外，移植中心、研究机构和製药公司之间的合作正在加速临床研究并促进新型移植疗法的创新和采用。

市场限制因素：

儘管骨髓移植市场预计将显着成长，但仍面临与手术併发症、移植相关发生率和医疗基础设施限制相关的课题。移植的高昂费用，加上移植物排斥、感染和 GVHD 的风险，给患者和医疗保健系统带来了经济和临床负担，限制了移植服务的广泛普及。此外，捐赠者可用性、HLA 匹配和移植后护理方面的差异也会导致移植结果和患者存活率的差异，因此需要全面的患者评估和个别化治疗方法。

市场机会：

在细胞疗法、再生医学和免疫疗法进步的推动下，骨髓移植市场提供了充满希望的机会。单倍体移植、离体移植操作和嵌合抗原受体 (CAR) T 细胞疗法等新兴趋势正在彻底改变移植策略，并为难治性疾病和復发性恶性肿瘤患者提供治疗选择。此外，对精准医学、基因组学和生物标记发现的投资将有助于患者选择、治疗优化和长期监测，从而提高移植疗效并减少与治疗相关的毒性。此外，移植中心、生物技术公司和监管机构之间的策略合作伙伴关係将加速下一代移植产品和治疗的创新和监管审批。

本报告解决的关键问题

  • 推动全球骨髓移植市场成长的关键因素是什么？
  • 技术进步和临床研究如何影响移植技术和支持性治疗的发展？
  • 骨髓移植领域的市场参与者面临哪些主要课题与机会？
  • 骨髓移植服务成长潜力最大的地区和医疗机构在哪里？
  • 在骨髓移植的竞争格局中，领先公司采取哪些策略来提高产品创新、市场渗透和临床效果？

目录

第一章执行摘要

第二章 市值与预测对比

第 3 章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制

第 4 章主要市场趋势

第五章 关键成功因素

第六章 全球骨髓移植市场分析（金额）

  • 过去的市场（金额）分析，2019-2023
  • 当前和未来市场（价值）预测，2024-2031

第七章市场背景

  • 宏观经济因素
  • 预测变量 - 相关性和影响
  • 市场动态

第 8 章依移植类型划分的全球骨髓移植市场分析

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2031
    • 自体骨髓移植
    • 同种异体骨髓移植
  • 依移植类型的市场吸引力分析

第九章全球骨髓移植市场适应症分析

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2031
    • 白血病
    • 淋巴瘤
    • 骨髓瘤
    • 骨髓增生异常
    • 骨髓增生性肿瘤
    • 再生障碍性贫血
    • 实体肿瘤
    • 镰状细胞性贫血
    • 地中海型贫血
    • 其他
  • 依症状进行市场吸引力分析

第 10 章全球骨髓移植市场分析（依最终用户）

  • 简介/主要发现
  • 过去的市场规模（金额）分析，2019-2023
  • 当前和未来市场规模（金额）分析和预测，2024-2031
    • 医院
    • 多学科诊所
    • 门诊手术中心
  • 最终用户的市场吸引力分析

第十一章全球骨髓移植市场分析（依地区）

  • 介绍
  • 过去的市场规模（金额）分析，2019-2023
  • 当前市场规模（金额）分析与预测，2024-2031
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 区域市场吸引力分析

第十二章北美骨髓移植市场分析

第十三章拉丁美洲骨髓移植市场分析

第十四章欧洲骨髓移植市场分析

第十五章南亚骨髓移植市场分析

第十六章东亚骨髓移植市场分析

第十七章大洋洲骨髓移植市场分析

第十八章中东与非洲骨髓移植市场分析

第 19 章 竞争分析

  • 比赛仪表板
  • 衝突详情
    • Lonza Group Ltd.
    • Merck Millipore Corporation
    • Sanofi-Aventis LLC.
    • STEMCELL Technologies.
    • American Type Culture Collection（ATCC）Inc
    • ReeLabs Pvt. Ltd.
    • HemaCare

第 20 章使用的假设和首字母缩略词

第21章研究方法论

简介目录
Product Code: PMRREP4288

Persistence Market Research presents a comprehensive analysis of the global Bone Marrow Transplantation Market, offering insights into market trends, growth drivers, challenges, and emerging opportunities. This study provides a detailed examination of the market, highlighting crucial statistics and projections that delineate the market's trajectory from 2024 to 2031.

Key Insights:

  • Bone Marrow Transplantation Market Size (2024): USD 11,137 Million
  • Projected Market Value (2031): USD 14,336 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 3.67%

Bone Marrow Transplantation Market - Report Scope:

The Bone Marrow Transplantation Market encompasses procedures and technologies vital for treating various hematological disorders, solid tumors, and autoimmune diseases. These include allogeneic and autologous transplantations, hematopoietic stem cell collection, conditioning regimens, and supportive care measures. The market caters to hospitals, transplant centers, and specialty clinics, providing advanced transplantation solutions to improve patient outcomes and quality of life.

Market Growth Drivers:

The global Bone Marrow Transplantation Market is propelled by several growth factors. The increasing prevalence of hematological malignancies and autoimmune disorders, coupled with advancements in transplant techniques and supportive care, drive demand for bone marrow transplantation procedures. Technological innovations in graft processing, immunosuppressive therapies, and graft-versus-host disease (GVHD) prophylaxis enhance transplant success rates and expand the applicability of transplantation across a broader patient population. Additionally, collaborative efforts between transplant centers, research institutions, and pharmaceutical companies accelerate clinical research, driving innovation and adoption of novel transplantation therapies.

Market Restraints:

Despite significant growth prospects, the Bone Marrow Transplantation Market faces challenges related to procedural complications, transplant-related morbidities, and healthcare infrastructure limitations. The high cost of transplantation, coupled with the risk of graft rejection, infection, and GVHD, poses financial and clinical burdens on patients and healthcare systems, limiting widespread access to transplantation services. Moreover, disparities in donor availability, HLA matching, and post-transplant care contribute to variations in transplant outcomes and patient survival rates, underscoring the need for comprehensive patient evaluation and personalized treatment approaches.

Market Opportunities:

The Bone Marrow Transplantation Market presents promising opportunities driven by advances in cellular therapy, regenerative medicine, and immunotherapy. Emerging trends such as haploidentical transplantation, ex vivo graft manipulation, and chimeric antigen receptor (CAR) T-cell therapy revolutionize transplant strategies, offering curative options for patients with refractory diseases and relapsed malignancies. Furthermore, investments in precision medicine, genomics, and biomarker discovery facilitate patient selection, treatment optimization, and long-term monitoring, thereby improving transplant efficacy and reducing treatment-related toxicities. Additionally, strategic collaborations between transplant centers, biotechnology firms, and regulatory agencies foster innovation and regulatory approval for next-generation transplantation products and therapies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Bone Marrow Transplantation Market globally?
  • How are technological advancements and clinical research shaping the evolution of transplantation techniques and supportive care measures?
  • What are the key challenges and opportunities facing market participants in the field of bone marrow transplantation?
  • Which geographic regions and healthcare settings offer the highest growth potential for bone marrow transplantation services?
  • What strategies are leading companies employing to enhance product innovation, market penetration, and clinical outcomes in the competitive landscape of bone marrow transplantation?

Competitive Intelligence and Business Strategy:

Leading players in the global Bone Marrow Transplantation Market, including transplant centers, biopharmaceutical companies, and research organizations, focus on innovation, clinical evidence generation, and market expansion to maintain a competitive edge. These entities invest in research and development to develop novel transplantation techniques, graft engineering strategies, and immunomodulatory therapies aligned with clinical guidelines and patient needs. Moreover, strategic partnerships with academic institutions, patient advocacy groups, and government agencies facilitate collaborative research, clinical trial enrollment, and regulatory approval for transplantation products and therapies. Furthermore, emphasis on post-transplant surveillance, long-term follow-up, and patient-reported outcomes ensures optimal transplant outcomes and patient satisfaction in the dynamic landscape of bone marrow transplantation.

Key Companies Profiled:

  • National Marrow Donor Program
  • DKMS
  • Be The Match
  • Lonza Group
  • Regen Biopharma Inc.
  • Celgene Corporation
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • Pfizer Inc.
  • Others.

Bone Marrow Transplantation Market Segmentation:

By End User

  • Hospitals
  • Multispecialty Clinics
  • Ambulatory Surgical Centers

By Transplant Type

  • Autologous Bone Marrow Transplant
  • Allogeneic Bone marrow Transplant

By Disease Indication

  • Leukemia
  • Lymphoma
  • Myeloma
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

2. Market Value and Forecast Comparison

3. Market Overview

  • 3.1. Market Coverage / Taxonomy
  • 3.2. Market Definition / Scope / Limitations

4. Key Market Trends

5. Key Success Factors

6. Global Bone Marrow Transplantation Market Value Analysis 2019-2023 and Forecast, 2024-2031

  • 6.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 6.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 6.2.1. Y-o-Y Growth Trend Analysis
    • 6.2.2. Absolute $ Opportunity Analysis

7. Market Background

  • 7.1. Macro-Economic Factors
    • 7.1.1. Increasing per capita healthcare expenditure
    • 7.1.2. Changes in economic structure and employment
  • 7.2. Forecast Factors - Relevance & Impact
  • 7.3. Market Dynamics
    • 7.3.1. Drivers
    • 7.3.2. Restraints
    • 7.3.3. Opportunity Analysis

8. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by Transplantation Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Transplantation Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Transplantation Type, 2024-2031
    • 8.3.1. Autologous Bone Marrow Transplant
    • 8.3.2. Allogeneic Bone Marrow Transplant
  • 8.4. Market Attractiveness Analysis By Transplantation Type

9. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by Indication

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Indication, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2024-2031
    • 9.3.1. Leukemia
    • 9.3.2. Lymphoma
    • 9.3.3. Myeloma
    • 9.3.4. Myelodysplasia
    • 9.3.5. Myeloproliferative Neoplasms
    • 9.3.6. Aplastic Anemia
    • 9.3.7. Solid tumors
    • 9.3.8. Sickle cell Anemia
    • 9.3.9. Thalassemia
    • 9.3.10. Others
  • 9.4. Market Attractiveness Analysis By Indication

10. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
    • 10.3.1. Hospitals
    • 10.3.2. Multispecialty Clinics
    • 10.3.3. Ambulatory Surgical Centers
  • 10.4. Market Attractiveness Analysis By End User

11. Global Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Transplantation Type
    • 12.3.3. By Indication
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. Latin America Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Mexico
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Transplantation Type
    • 13.3.3. By Indication
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
  • 13.5. Drivers and Restraints - Impact Analysis

14. Europe Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. Russia
      • 14.3.1.7. Rest of Europe
    • 14.3.2. By Transplantation Type
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. South Asia Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Thailand
      • 15.3.1.3. Indonesia
      • 15.3.1.4. Malaysia
      • 15.3.1.5. Rest of South Asia
    • 15.3.2. By Transplantation Type
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. East Asia Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Transplantation Type
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. Oceania Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Transplantation Type
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
  • 17.5. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Bone Marrow Transplantation Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. Rest of Middle East and Africa
    • 18.3.2. By Transplantation Type
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
  • 18.5. Drivers and Restraints - Impact Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Deep Dive
    • 19.2.1. Lonza Group Ltd.
      • 19.2.1.1. Overview
      • 19.2.1.2. Analyst Commentary
      • 19.2.1.3. Key Financials
      • 19.2.1.4. Recent Developments
      • 19.2.1.5. Strategy Overview
    • 19.2.2. Merck Millipore Corporation
      • 19.2.2.1. Overview
      • 19.2.2.2. Analyst Commentary
      • 19.2.2.3. Key Financials
      • 19.2.2.4. Recent Developments
      • 19.2.2.5. Strategy Overview
    • 19.2.3. Sanofi-Aventis LLC.
      • 19.2.3.1. Overview
      • 19.2.3.2. Analyst Commentary
      • 19.2.3.3. Key Financials
      • 19.2.3.4. Recent Developments
      • 19.2.3.5. Strategy Overview
    • 19.2.4. STEMCELL Technologies.
      • 19.2.4.1. Overview
      • 19.2.4.2. Analyst Commentary
      • 19.2.4.3. Key Financials
      • 19.2.4.4. Recent Developments
      • 19.2.4.5. Strategy Overview
    • 19.2.5. American Type Culture Collection (ATCC) Inc
      • 19.2.5.1. Overview
      • 19.2.5.2. Analyst Commentary
      • 19.2.5.3. Key Financials
      • 19.2.5.4. Recent Developments
      • 19.2.5.5. Strategy Overview
    • 19.2.6. ReeLabs Pvt. Ltd.
      • 19.2.6.1. Overview
      • 19.2.6.2. Analyst Commentary
      • 19.2.6.3. Key Financials
      • 19.2.6.4. Recent Developments
      • 19.2.6.5. Strategy Overview
    • 19.2.7. HemaCare
      • 19.2.7.1. Overview
      • 19.2.7.2. Analyst Commentary
      • 19.2.7.3. Key Financials
      • 19.2.7.4. Recent Developments
      • 19.2.7.5. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology